Reni Benjamin
Stock Analyst at JMP Securities
(1.41)
# 3,340
Out of 4,761 analysts
169
Total ratings
37.24%
Success rate
-12.36%
Average return
Main Sectors:
Stocks Rated by Reni Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines | Reiterates: Market Outperform | $125 | $92.25 | +35.50% | 20 | Feb 14, 2025 | |
| WU The Western Union Company | Reiterates: Market Perform | n/a | $10.66 | - | 1 | Feb 6, 2025 | |
| WDAY Workday | Reiterates: Market Outperform | $315 | $256.39 | +22.86% | 1 | Feb 6, 2025 | |
| UBER Uber Technologies | Reiterates: Market Perform | n/a | $78.89 | - | 1 | Feb 6, 2025 | |
| STE STERIS | Reiterates: Market Outperform | $265 | $220.56 | +20.15% | 1 | Feb 6, 2025 | |
| KURA Kura Oncology | Reiterates: Market Outperform | $28 | $8.25 | +239.39% | 9 | Feb 6, 2025 | |
| ACET Adicet Bio | Reiterates: Market Perform | n/a | $0.97 | - | 4 | Feb 6, 2025 | |
| INBX Inhibrx Biosciences | Reiterates: Market Perform | n/a | $12.56 | - | 8 | Jan 22, 2025 | |
| INCY Incyte | Reiterates: Market Perform | n/a | $72.11 | - | 26 | Jan 14, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Market Outperform | $12 → $4 | $1.38 | +189.86% | 5 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $32 → $26 | $11.66 | +122.98% | 12 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $17 | $1.77 | +860.45% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $7 → $4 | $0.87 | +359.29% | 3 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $6 | $0.96 | +526.63% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.01 | - | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $22.12 | - | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Outperform | $32 | $22.12 | +44.67% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $5 | $0.41 | +1,125.19% | 8 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $15 → $2 | $1.32 | +51.52% | 4 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $25 → $23 | $5.78 | +297.92% | 10 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.17 | - | 6 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $8 → $4 | $2.10 | +90.48% | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $3.94 | - | 4 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $28 → $17 | $4.22 | +302.84% | 3 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.96 | - | 2 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.48 | - | 3 | Nov 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Outperform | n/a | $7.27 | - | 4 | Jun 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Market Perform | n/a | $7.66 | - | 3 | Jun 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $2.76 | - | 2 | Feb 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $16 | $0.56 | +2,759.70% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $10 | $15.84 | -36.87% | 2 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $22 → $12 | $30.88 | -61.14% | 1 | Sep 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $10.08 | - | 1 | Nov 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.37 | - | 2 | Nov 10, 2017 |
Blueprint Medicines
Feb 14, 2025
Reiterates: Market Outperform
Price Target: $125
Current: $92.25
Upside: +35.50%
The Western Union Company
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $10.66
Upside: -
Workday
Feb 6, 2025
Reiterates: Market Outperform
Price Target: $315
Current: $256.39
Upside: +22.86%
Uber Technologies
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $78.89
Upside: -
STERIS
Feb 6, 2025
Reiterates: Market Outperform
Price Target: $265
Current: $220.56
Upside: +20.15%
Kura Oncology
Feb 6, 2025
Reiterates: Market Outperform
Price Target: $28
Current: $8.25
Upside: +239.39%
Adicet Bio
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.97
Upside: -
Inhibrx Biosciences
Jan 22, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $12.56
Upside: -
Incyte
Jan 14, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $72.11
Upside: -
Werewolf Therapeutics
Jan 14, 2025
Maintains: Market Outperform
Price Target: $12 → $4
Current: $1.38
Upside: +189.86%
Dec 18, 2024
Maintains: Market Outperform
Price Target: $32 → $26
Current: $11.66
Upside: +122.98%
Dec 11, 2024
Reiterates: Market Outperform
Price Target: $17
Current: $1.77
Upside: +860.45%
Dec 11, 2024
Reiterates: Market Outperform
Price Target: $7 → $4
Current: $0.87
Upside: +359.29%
Dec 11, 2024
Downgrades: Market Perform
Price Target: $6
Current: $0.96
Upside: +526.63%
Nov 5, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $3.01
Upside: -
Nov 4, 2024
Initiates: Market Perform
Price Target: n/a
Current: $22.12
Upside: -
Nov 4, 2024
Initiates: Market Outperform
Price Target: $32
Current: $22.12
Upside: +44.67%
Sep 16, 2024
Reiterates: Market Outperform
Price Target: $5
Current: $0.41
Upside: +1,125.19%
Jul 26, 2024
Maintains: Market Outperform
Price Target: $15 → $2
Current: $1.32
Upside: +51.52%
Jun 20, 2024
Maintains: Market Outperform
Price Target: $25 → $23
Current: $5.78
Upside: +297.92%
Jan 5, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.17
Upside: -
Aug 8, 2022
Maintains: Market Outperform
Price Target: $8 → $4
Current: $2.10
Upside: +90.48%
Nov 12, 2020
Upgrades: Market Perform
Price Target: n/a
Current: $3.94
Upside: -
Nov 10, 2020
Downgrades: Outperform
Price Target: $28 → $17
Current: $4.22
Upside: +302.84%
Dec 3, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.96
Upside: -
Nov 15, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $0.48
Upside: -
Jun 14, 2019
Reinstates: Outperform
Price Target: n/a
Current: $7.27
Upside: -
Jun 14, 2019
Reinstates: Market Perform
Price Target: n/a
Current: $7.66
Upside: -
Feb 7, 2019
Upgrades: Market Perform
Price Target: n/a
Current: $2.76
Upside: -
Oct 22, 2018
Maintains: Outperform
Price Target: $20 → $16
Current: $0.56
Upside: +2,759.70%
Oct 12, 2018
Maintains: Outperform
Price Target: $11 → $10
Current: $15.84
Upside: -36.87%
Sep 25, 2018
Downgrades: Outperform
Price Target: $22 → $12
Current: $30.88
Upside: -61.14%
Nov 15, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $10.08
Upside: -
Nov 10, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $0.37
Upside: -